Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 11, 2026

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies

Published on: September 23, 2014

Tissue microarrays in clinical urology--technical considerations.

Mario W Kramer1, Axel S Merseburger, Jorg Hennenlotter

  • 1Department of Urology, Eberhard-Karls-University Tübingen, Tübingen, Germany. mariokramer@gmail.com

Scandinavian Journal of Urology and Nephrology
|October 2, 2007
PubMed
Summary

Tissue microarray (TMA) technology allows high-throughput analysis of molecular targets in many samples. This cost-effective method is useful for studying DNA, RNA, and proteins, particularly in bladder and prostate cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nectin-4 Expression in Muscle-Invasive Bladder Cancer Is Associated with Growth-Related and Inflammatory Signaling Pathways.

International journal of molecular sciences·2026
Same author

Topographical and stage-related expression of nectin-4 in prostate cancer.

Central European journal of urology·2026
Same author

Editorial Comment on to Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis.

International urology and nephrology·2026
Same author

Unresolved questions in the sequencing of systemic therapy for advanced urothelial carcinoma.

World journal of urology·2026
Same author

Significant differences in CD276 (B7H3) expression between female and male bladder cancer tissue samples: An exploratory study.

Current urology·2026

Area of Science:

  • Biotechnology
  • Molecular Pathology
  • Cancer Research

Background:

  • The tissue microarray (TMA) technique facilitates high-throughput analysis of molecular targets.
  • It enables simultaneous examination of DNA, RNA, and protein expression.
  • TMA is recognized for its cost and time efficiency in research.

Purpose of the Study:

  • To review the technical aspects of the tissue microarray (TMA) technique.
  • To outline the advantages and limitations of TMA.
  • To provide an overview of TMA applications in bladder and prostate cancer studies.

Main Methods:

  • Review of existing literature on tissue microarray technology.
  • Analysis of technical considerations for TMA implementation.
  • Examination of case studies utilizing TMA in urological oncology.

More Related Videos

Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer
12:03

Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer

Published on: June 10, 2022

Related Experiment Videos

Last Updated: Jul 11, 2026

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies

Published on: September 23, 2014

Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer
12:03

Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer

Published on: June 10, 2022

Main Results:

  • TMA offers a standardized, high-throughput approach for molecular analysis.
  • Key advantages include efficiency and cost-effectiveness.
  • Weaknesses relate to potential tissue representativeness and technical challenges.

Conclusions:

  • Tissue microarray (TMA) is a valuable tool for molecular pathology and cancer research.
  • Its efficiency and standardization make it suitable for large-scale studies.
  • TMA has demonstrated utility in advancing the understanding of bladder and prostate cancers.